Search for: "ELI LILLY & CO."
Results 381 - 400
of 1,008
Sorted by Relevance
|
Sort by Date
30 Oct 2008, 11:34 am
It is a twice daily injection which is sold in a pre-filled pen by Amylin Pharmaceuticals and Eli Lilly & Co. [read post]
1 Nov 2018, 6:26 am
The warning applies to the class of SGLT2 inhibitors, specifically, Johnson & Johnson’s Invokana (canagliflozin), AstraZeneca Plc’s Farxiga (dapagliflozin), and Eli Lilly & Co. [read post]
27 Mar 2007, 12:05 pm
Meridian, where Eli Lilly and Co. plans to vacate a total of 99,000 square feet. [read post]
25 Jul 2014, 4:30 pm
Eli Lilly & Co., 654 F.3d 347 (CA2 2011). [read post]
18 Mar 2011, 1:12 pm
The investigation is based on a January 20, 2011 complaint and February 9 and 16 letters supplementing the complaint filed by Eli Lilly and Company of Indianapolis, Indiana alleging violation of Section 337 in the importation into the U.S. and sale of certain gemcitabine and products containing same that infringe U.S. [read post]
26 Mar 2010, 4:15 am
Eli Lilly & Co., Fed. [read post]
23 Mar 2021, 1:35 pm
Specifically, besides Xeljanz there are two other JAK inhibitors approved by the FDA: Olumiant (baricitinib) from Eli Lilly & Co.; and, Rinvoq (upadacitinib) from AbbVie. [read post]
27 Feb 2020, 8:21 am
Eli Lilly and Company, SCT Docket No. [read post]
14 May 2015, 4:00 am
For example: (a) In Dow Chemical Co. v. [read post]
20 Jun 2011, 7:01 pm
Court of Appeals for the Federal Circuit in Eli Lilly & Co. v. [read post]
4 Nov 2009, 4:03 am
Stakeholders react to draft report (IP Watch) US: District Court S D New York denies motions to dismiss in gene patent case: Association for Molecular Pathology v USPTO (Inventive Step) (Patent Docs) (Patent Baristas) (Ars Technica) (The IP Factor) (Patently-O) (IP Watch) Products Ceclor (Cefaclor) – Canada: Eli Lilly successful in patent infringement action against Apotex (Pharmacapsules @ Gowlings) Oxytrol (Oxybutynin) – US: Watson and Barr settle patent… [read post]
19 Oct 2010, 12:20 pm
Eli Lilly & Co., 2010 WL 4024922 (D.S.D. [read post]
4 Nov 2009, 4:03 am
Stakeholders react to draft report (IP Watch) US: District Court S D New York denies motions to dismiss in gene patent case: Association for Molecular Pathology v USPTO (Inventive Step) (Patent Docs) (Patent Baristas) (Ars Technica) (The IP Factor) (Patently-O) (IP Watch) Products Ceclor (Cefaclor) – Canada: Eli Lilly successful in patent infringement action against Apotex (Pharmacapsules @ Gowlings) Oxytrol (Oxybutynin) – US: Watson and Barr settle… [read post]
4 Nov 2009, 4:03 am
Stakeholders react to draft report (IP Watch) US: District Court S D New York denies motions to dismiss in gene patent case: Association for Molecular Pathology v USPTO (Inventive Step) (Patent Docs) (Patent Baristas) (Ars Technica) (The IP Factor) (Patently-O) (IP Watch) Products Ceclor (Cefaclor) - Canada: Eli Lilly successful in patent infringement action against Apotex (Pharmacapsules @ Gowlings) Oxytrol (Oxybutynin) - US: Watson and Barr settle patent litigation (SmartBrief)… [read post]
12 Oct 2016, 8:48 am
The Motion On September 28, 2016, several plaintiffs who have filed suit against Eli Lilly and Co., the maker of Cialis (another erectile dysfunction drug), asked the judge presiding over the Viagra MDL to permit all plaintiffs suing Eli Lilly to transfer their cases to MDL 2691. [read post]
6 Aug 2007, 9:21 pm
Eli Lilly & Co., 33 F.3d 716 (6th Cir.1994), such a motion should only be denied where a defendant can show plain legal prejudice flowing from the dismissal. [read post]
15 Jul 2010, 2:39 pm
Eli Lilly & Co., 192 Cal. [read post]
11 Oct 2018, 12:57 am
Here the court agreed with MSD’s appeal in that the HIPO’s interpretation of the Eli Lilly judgment was wrong: it does not follow from this judgment that the concerned active ingredient should be mentioned by name or by structure in the description. [read post]
7 Nov 2007, 6:57 pm
”You can read the Order, dated August 17th, 2007, on Acquirelaw™ at In re Eli Lilly & Co. [read post]
26 Apr 2007, 2:32 am
The Coalition for Patent Fairness was well-prepared for the introduction of the patent reform bill on April 18, 2007. 3M is a member of the Coalition for 21st Century Patent Reform, which includes some pharma companies (eg, AstraZeneca, Eli Lilly, GlaxoSmithKline, Hoffman-La Roche, Johnson & Johnson, Merck, Millennium Pharmaceuticals).BusinessWeek noted that the Biotechnology Industry Organization [BIO] has expressed opposition to several aspects of the bill.One notes that… [read post]
